NewslettersProstate Cell NewsPlasma Extracellular Vesicle circRNA Signature and Resistance to Abiraterone in Metastatic Castration-Resistant Prostate CancerBy Noshin Noorjahan - January 27, 20230303582 mCRPC patients undergoing first-line abiraterone therapy from four institutions were sorted by three phases: discovery, training, and validation.[British Journal of Cancer]Abstract